Pharmacokinetics and Safety of Stavudine in HIV‐Infected Pregnant Women and Their Infants: Pediatric AIDS Clinical Trials Group Protocol 332
Nancy A. Wade, Sandra Burchett(Harvard University), Lisa M. Frenkel(Infectious Disease Research Institute), Sharon Huang(FuelCell Energy (United States)), David E. Shapiro(Intercept Pharmaceuticals (United States)), Anita Mathias(Gilead Sciences (United States)), Renee Samelson(Albany Medical Center Hospital), Jane Hitti(University of Washington), Mobeen H. Rathore, Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Isaac Delke(SUNY Upstate Medical University), Gregory Ciupak(Rutgers, The State University of New Jersey), Mary E. Smith(National Institutes of Health), D. Heather Watts(National Institutes of Health), Salih Yasin(University of Miami), Jashvant D. Unadkat(University of Washington)
Cited by 35
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k